1. Home
  2. What Is CGM?

Easy monitoring*1 with continuous
data collection2

 

Make treatment decisions anytime, high or low, no fingersticks required

A CGM system like FreeStyle Libre 2 provides easy visibility to hidden problems.*A small sensor-based system provides up to 14 days and nights of glucose readings without fingersticks.†2 With glucose alarms, rest assured your patients will know when they’re high or low. The FreeStyle Libre 2 system provides real-time glucose readings every minute with a simple scan.2

 

For illustrative purposes only. Not actual patient data.

Challenges to revealing a more complete
glucose picture

Patients with diabetes do not often make a clear connection between glycemic control
and certain self-management behaviors, which can result in4:

Not meeting their A1c goals

Not regularly monitoring their
glucose levels

Not making diet and exercise
changes as needed

Whether patients meet A1c goals*5 or not, they may experience significant time outside of target range6

 

  Above Target Range (>180 mg/dL)      In Target Range (70-180 mg/dL)     Below Target Range (<70 mg/dL)

For illustrative purposes only. Not actual patient data. 
Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.

The FreeStyle Libre 2 system reveals a complete picture*3 without the pain and hassle of fingersticks*

For patients with type 2 diabetes using blood glucose monitoring (BGM), highs and
lows aren't always easy to see.*3

For illustrative purposes only. Not actual patient data.

The use of fingerstick testing*7 or A1c alone*5 do not fully reveal glycemic patterns and trends,
but with the FreeStyle Libre 2 system, hidden glucose patterns are uncovered.*3

Who can benefit from the FreeStyle Libre 2 system?

  • The FreeStyle Libre 2 system provides unsurpassed 14-day accuracy2 for adults and children,§ and is proven to help children and teens§ achieve better glycemic control vs BGM.*ǁ8

  • The FreeStyle Libre 2 system has been observed to reduce A1C similar to a diabetes oral medication.*9,10

Use of the FreeStyle Libre 2 system resulted in improved control vs blood glucose testing in adult patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) patients.*¶#1,11

 T1D patients (IMPACT Trial)*¶11

  • ~3x increase in glucose monitoring/15.1 scans/day vs 5.6 blood glucose tests

  • 38%12 reduction in time spent in hypoglycemia

  • 40% reduction in time spent in nocturnal hypoglycemia

  • 50% reduction in time spent in serious hypoglycemia

  • 19% reduction in time spent in hyperglycemia (>240mg/dL)

  • Increased time in target range by 1 hour

T2D patients (REPLACE Trial)*#1

  • ~2x increase in glucose monitoring/8.3 scans/day vs 3.8 blood glucose tests

  • 41%12 reduction in time spent in hypoglycemia

  • 54% reduction in time spent in nocturnal hypoglycemia

  • 53% reduction in time spent in serious hypoglycemia

  • Statistically significant A1c reduction of 0.33% in T2D patients <65 years old

Medicare coverage is available for the FreeStyle Libre 2 system if a compatible smartphone is used in conjunction with the FreeStyle Libre 2 reader to review glucose data. Medicare coverage and other third party payor criteria apply. As a courtesy, Abbott provides the most up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage of payment for our products or reimburse customers for claims that are denied by third party payors.

The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.

* Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.

† Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.

​​​​‡ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.

§ Freestyle Libre 2 system is indicated for use in people with diabetes age 4 and older.

ǁ Self-monitoring of blood glucose.

 IMPACT Trial: A randomized, controlled 6-month trial to evaluate the effectiveness of FreeStyle Libre glucose monitoring system (n=119) on glycemic control for the self-management of type 1 diabetes (T1D) as compared to self-monitored blood glucose (SMBG; n=120).

# REPLACE Trial: A randomized, controlled trial to evaluate the impact of FreeStyle Libre glucose monitoring system (n=149) on HbA1c in people with type 2 diabetes (T2D) taking multiple daily doses of insulin at 6 months compared to self-monitored blood glucose (SMBG; n=75).

References: 1. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (February 2017): 55-73. https://doi.org/ 10.1007/s13300-016-0223-6. 2. FreeStyle Libre 2 User's Manual. 3. Unger, Jeff, Pamela Kushner, and John E. Anderson. "Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care." Postgraduate Medicine 132, no. 4 (March 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393. 4. Schnell, Oliver, et al. "Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research." Diabetes Care 38, no. 9 (September 2015): 1627-1633. https://doi.org/10.2337/dc14-2919. 5. Hirsch, Irl B., and Eugene E. Wright. "Using flash continuous glucose monitoring in primary practice." Clinical Diabetes 37, no. 2 (April 2019): 150-161. https://doi.org/10.2337/cd18-0054. 6. Battelino, Tadej, et al. "Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on Time in Range." Diabetes Care 42, no. 8 (June 2019): 1593-1603. https://doi.org/10.2337/dci19-0028. 7. Janapala, Rajesh Naidu, et al. "Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-Analysis." Cureus 11, no. 9 (September 2019): e5634. https://doi.org/10.7759/cureus.5634. 8. Campbell, Fiona M., et al. "Outcomes of Using Flash Glucose Monitoring technology by Children and young people with Type 1 Diabetes in a Single Arm Study." Pediatric Diabetes 19, no. 7 (November 2018): 1294-1301. https://doi.org/10.1111/pedi.12735. 9. Wright, Eugene E., et al. "Use of Flash Continuous Glucose Monitoring Is Associated With A1c Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy." Diabetes Spectrum (February 2021): ds200069. https://doi.org/10.2337/ds20-0069. 10. Chaudhary, Arun. et al. "Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management." Frontiers In Endocrinology 8, no. 6 (January 2017). https://doi.org/10.3389/fendo.2017.00006. 11. Bolinder, Jan, et al. "Novel Glucose-Sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-Masked, Randomised Controlled Trial." The Lancet 10057, no. 388 (September 2016): 2254-2263. https://doi.org/10.1016/S0140-6736(16)31535-5. 12. Data on file. Abbott Diabetes Care.

ADC-42701 Ver 1.0 09/21

Important Safety Information

FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

FreeStyle Libre 2 system: Failure to use FreeStyle Libre 2 system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

FreeStyle Libre Pro: The FreeStyle Libre Pro Flash Glucose Monitoring System is a professional continuous glucose monitoring (CGM) device indicated for detecting trends and tracking patterns and glucose level excursions above or below the desired range, facilitating therapy adjustments in persons (age 18 and older) with diabetes. The system is intended for use by health care professionals and requires a prescription.

IMPORTANT: The device may inaccurately indicate hypoglycemia. The results of the clinical study conducted for this device showed that 40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81-160 mg/dL. Therefore, interpretation of the FreeStyle Libre Pro Flash Glucose Monitoring System readings should only be based on the trends and patterns analyzed through time using the reports available per the intended use.

CONTRAINDICATIONS: Remove the Sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: The FreeStyle Libre Pro System does not provide real-time results and patients should adhere to their blood glucose monitoring routine while using the system. If a sensor breaks, contact physician and call Customer Service. Patients with high levels of ascorbic acid (Vitamin C) or salicylic acid (used in Aspirin) or severe dehydration or excessive water loss may experience inaccurate results with this system. The FreeStyle Libre Pro System is not approved for pregnant women, persons on dialysis, or recommended for critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. Review all product information before use or contact Abbott Toll Free (855-632-5297) (or visit provider.myfreestyle.com) for detailed indications for use and safety information.

The product images are for illustrative purposes only.

The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-45115 Ver 4.0 03/22

Cookie Policy

FreeStyle Libre uses cookies to give you the best possible service. By using our website, you consent to the use of cookies. Data protection